Wilson Sonsini Goodrich & Rosati is pleased to support the Viva Biotech Partnering Summit. The conference aims to build up a stage for professionals to gather and discuss how to empower global biotech startups to realize the transition from early stage to a fully mature company.

There will be 25 Viva BioInnovatro (VBI) portfolio companies joining the Demo Day Pro to showcase their cutting edge technologies and innovative drug discoveries in 5 categories: 1) CNS Indications, 2) Drug Conjugates, 3) Oncology, 4) Gene & Cell Therapy, and 5) Inflammatory & Metabolic Diseases. Additionally, VBI portfolio companies will host virtual booths for 1:1 partnering. Investors and approved participants can connect with the founders and CEOs through video calls and message chat.